FDA Inaction on Hair Loss Drug ' s Suicide Risk Sparks Lawsuit FDA Inaction on Hair Loss Drug ' s Suicide Risk Sparks Lawsuit
The lawsuit seeks to force the FDA to act on a 4-year-old petition calling for removal of the popular hair loss drug from the market over risks that include depression and suicidal ideation.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Psychiatry News Source Type: news
More News: Alopecia | Depression | Dermatology | Lawsuits | Legislation | Psychiatry | Skin | Suicide